Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jul;41(7):1413–1422. doi: 10.1128/aac.41.7.1413

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

N J White 1
PMCID: PMC163932  PMID: 9210658

Full Text

The Full Text of this article is available as a PDF (170.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alin M. H., Björkman A., Ashton M. In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1990 Sep-Oct;84(5):635–637. doi: 10.1016/0035-9203(90)90129-3. [DOI] [PubMed] [Google Scholar]
  2. Chulay J. D., Haynes J. D., Diggs C. L. Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp Parasitol. 1983 Feb;55(1):138–146. doi: 10.1016/0014-4894(83)90007-3. [DOI] [PubMed] [Google Scholar]
  3. Craig W. A. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. J Antimicrob Chemother. 1993 May;31 (Suppl 500):149–158. doi: 10.1093/jac/31.suppl_d.149. [DOI] [PubMed] [Google Scholar]
  4. Dieckmann A., Jung A. Stage-specific sensitivity of Plasmodium falciparum to antifolates. Z Parasitenkd. 1986;72(5):591–594. doi: 10.1007/BF00925479. [DOI] [PubMed] [Google Scholar]
  5. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fontanet A. L., Walker A. M. Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. Am J Trop Med Hyg. 1993 Oct;49(4):465–472. doi: 10.4269/ajtmh.1993.49.465. [DOI] [PubMed] [Google Scholar]
  7. Gordeuk V. R., Thuma P. E., Brittenham G. M., Biemba G., Zulu S., Simwanza G., Kalense P., M'Hango A., Parry D., Poltera A. A. Iron chelation as a chemotherapeutic strategy for falciparum malaria. Am J Trop Med Hyg. 1993 Feb;48(2):193–197. doi: 10.4269/ajtmh.1993.48.193. [DOI] [PubMed] [Google Scholar]
  8. Harinasuta T., Bunnag D., Wernsdorfer W. H. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull World Health Organ. 1983;61(2):299–305. [PMC free article] [PubMed] [Google Scholar]
  9. Harinasuta T., Viravan C., Reid H. A. Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand. Lancet. 1967 May 27;1(7500):1117–1119. doi: 10.1016/s0140-6736(67)91703-5. [DOI] [PubMed] [Google Scholar]
  10. Hien T. T., White N. J. Qinghaosu. Lancet. 1993 Mar 6;341(8845):603–608. doi: 10.1016/0140-6736(93)90362-k. [DOI] [PubMed] [Google Scholar]
  11. Howard R. J., Gilladoga A. D. Molecular studies related to the pathogenesis of cerebral malaria. Blood. 1989 Dec;74(8):2603–2618. [PubMed] [Google Scholar]
  12. Jiang J. B., Li G. Q., Guo X. B., Kong Y. C., Arnold K. Antimalarial activity of mefloquine and qinghaosu. Lancet. 1982 Aug 7;2(8293):285–288. doi: 10.1016/s0140-6736(82)90268-9. [DOI] [PubMed] [Google Scholar]
  13. Karunaweera N. D., Grau G. E., Gamage P., Carter R., Mendis K. N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200–3203. doi: 10.1073/pnas.89.8.3200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kremsner P. G., Winkler S., Brandts C., Graninger W., Bienzle U. Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg. 1993 Nov;49(5):650–654. doi: 10.4269/ajtmh.1993.49.650. [DOI] [PubMed] [Google Scholar]
  15. Kwiatkowski D., Molyneux M. E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D. R., Grau G. E. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med. 1993 Feb;86(2):91–98. [PubMed] [Google Scholar]
  16. Landau I., Chabaud A., Cambie G., Ginsburg H. Chronotherapy of malaria: an approach to malaria chemotherapy. Parasitol Today. 1991 Dec;7(12):350–352. doi: 10.1016/0169-4758(91)90218-d. [DOI] [PubMed] [Google Scholar]
  17. Looareesuwan S., Viravan C., Vanijanonta S., Wilairatana P., Charoenlarp P., Canfield C., Kyle D. E. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian J Trop Med Public Health. 1993 Jun;24(2):230–234. [PubMed] [Google Scholar]
  18. Looareesuwan S., Viravan C., Webster H. K., Kyle D. E., Hutchinson D. B., Canfield C. J. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg. 1996 Jan;54(1):62–66. doi: 10.4269/ajtmh.1996.54.62. [DOI] [PubMed] [Google Scholar]
  19. Looareesuwan S., White N. J., Chittamas S., Bunnag D., Harinasuta T. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet. 1987 Nov 7;2(8567):1052–1055. doi: 10.1016/s0140-6736(87)91479-6. [DOI] [PubMed] [Google Scholar]
  20. Luxemburger C., Nosten F., Raimond S. D., Chongsuphajaisiddhi T., White N. J. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg. 1995 Nov;53(5):522–525. doi: 10.4269/ajtmh.1995.53.522. [DOI] [PubMed] [Google Scholar]
  21. Mapaba E., Hellgren U., Landberg-Lindgren A., Rombo L. Susceptibility of Plasmodium falciparum to quinine in vitro: effects of drug concentrations and time of exposure. Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):85–89. doi: 10.1016/0035-9203(95)90671-1. [DOI] [PubMed] [Google Scholar]
  22. Martin D. C., Arnold J. D. The effect of parasite populations on the curative action of pyrimethamine. Trans R Soc Trop Med Hyg. 1968;62(3):379–384. doi: 10.1016/0035-9203(68)90089-8. [DOI] [PubMed] [Google Scholar]
  23. Meek S. R., Doberstyn E. B., Gaüzère B. A., Thanapanich C., Nordlander E., Phuphaisan S. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border. Am J Trop Med Hyg. 1986 Mar;35(2):246–250. doi: 10.4269/ajtmh.1986.35.246. [DOI] [PubMed] [Google Scholar]
  24. Murphy J. R., Clyde D. F., Herrington D. A., Baqar S., Davis J. R., Palmer K., Cortese J. Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy. Antimicrob Agents Chemother. 1990 Apr;34(4):676–679. doi: 10.1128/aac.34.4.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nosten F., Imvithaya S., Vincenti M., Delmas G., Lebihan G., Hausler B., White N. Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine. Bull World Health Organ. 1987;65(6):891–896. [PMC free article] [PubMed] [Google Scholar]
  26. Nosten F., Luxemburger C., ter Kuile F. O., Woodrow C., Eh J. P., Chongsuphajaisiddhi T., White N. J. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis. 1994 Oct;170(4):971–977. doi: 10.1093/infdis/170.4.971. [DOI] [PubMed] [Google Scholar]
  27. Nosten F., ter Kuile F., Chongsuphajaisiddhi T., Luxemburger C., Webster H. K., Edstein M., Phaipun L., Thew K. L., White N. J. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet. 1991 May 11;337(8750):1140–1143. doi: 10.1016/0140-6736(91)92798-7. [DOI] [PubMed] [Google Scholar]
  28. Pasvol G., Newton C. R., Winstanley P. A., Watkins W. M., Peshu N. M., Were J. B., Marsh K., Warrell D. A. Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg. 1991 Dec;45(6):702–713. doi: 10.4269/ajtmh.1991.45.702. [DOI] [PubMed] [Google Scholar]
  29. Peters W., Robinson B. L. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'. Ann Trop Med Parasitol. 1984 Oct;78(5):459–466. doi: 10.1080/00034983.1984.11811850. [DOI] [PubMed] [Google Scholar]
  30. Prasad R. N., Prasad H., Virk K. J., Sharma V. P. Application of a simplified in-vivo test system for determining chloroquine resistance in Plasmodium falciparum. Bull World Health Organ. 1990;68(6):755–758. [PMC free article] [PubMed] [Google Scholar]
  31. Pukrittayakamee S., Viravan C., Charoenlarp P., Yeamput C., Wilson R. J., White N. J. Antimalarial effects of rifampin in Plasmodium vivax malaria. Antimicrob Agents Chemother. 1994 Mar;38(3):511–514. doi: 10.1128/aac.38.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. RAMAKRISHNAN S. P., PRAKASH S., CHOWDHURY D. S., BASU P. C. Studies on Plasmodium berghei Vincke and Lips, 1948. XXIX. The size of parasite population and its relation to the selection of a strain resistant to sulphadiazine. Indian J Malariol. 1961 Jun;15:95–106. [PubMed] [Google Scholar]
  33. ROLLO I. M. Daraprim resistance in experimental malarial infections. Nature. 1952 Sep 6;170(4323):415–415. doi: 10.1038/170415a0. [DOI] [PubMed] [Google Scholar]
  34. Rieckmann K., Suebsaeng L., Rooney W. Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand. Am J Trop Med Hyg. 1987 Sep;37(2):211–216. doi: 10.4269/ajtmh.1987.37.211. [DOI] [PubMed] [Google Scholar]
  35. Ross J. P. The Surgery of Arterial Disease and Injury. Br Med J. 1946 Jan 5;1(4435):1–4. [PMC free article] [PubMed] [Google Scholar]
  36. SHUTE P. G., MARYON M. A contribution to the problem of strains of human plasmodium. Riv Malariol. 1954 Jun;33(1-3):1–21. [PubMed] [Google Scholar]
  37. Silamut K., White N. J. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):436–443. doi: 10.1016/0035-9203(93)90028-o. [DOI] [PubMed] [Google Scholar]
  38. Smithuis F. M., van Woensel J. B., Nordlander E., Vantha W. S., ter Kuile F. O. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border. Antimicrob Agents Chemother. 1993 Sep;37(9):1977–1981. doi: 10.1128/aac.37.9.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Turaman C., Basco L. K., Le Bras J. Evaluating the efficacy of chloroquine in febrile Guinean children infected with Plasmodium falciparum by a simplified in vivo test. Bull World Health Organ. 1992;70(4):477–480. [PMC free article] [PubMed] [Google Scholar]
  40. Watt G., Shanks G. D., Phintuyothin P. Prognostic significance of rises in parasitaemia during treatment of falciparum malaria. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):359–360. doi: 10.1016/0035-9203(92)90217-z. [DOI] [PubMed] [Google Scholar]
  41. White N. J. Antimalarial drug resistance: the pace quickens. J Antimicrob Chemother. 1992 Nov;30(5):571–585. doi: 10.1093/jac/30.5.571. [DOI] [PubMed] [Google Scholar]
  42. White N. J. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol. 1992 Jul;34(1):1–10. doi: 10.1111/j.1365-2125.1992.tb04100.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. White N. J., Chapman D., Watt G. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):590–597. doi: 10.1016/0035-9203(92)90141-x. [DOI] [PubMed] [Google Scholar]
  44. White N. J., Krishna S. Treatment of malaria: some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):767–777. doi: 10.1016/0035-9203(89)90322-2. [DOI] [PubMed] [Google Scholar]
  45. White N. J., Krishna S., Waller D., Craddock C., Kwiatkowski D., Brewster D. Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria. Lancet. 1989 Dec 2;2(8675):1313–1316. doi: 10.1016/s0140-6736(89)91918-1. [DOI] [PubMed] [Google Scholar]
  46. White N. J., Miller K. D., Churchill F. C., Berry C., Brown J., Williams S. B., Greenwood B. M. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med. 1988 Dec 8;319(23):1493–1500. doi: 10.1056/NEJM198812083192301. [DOI] [PubMed] [Google Scholar]
  47. Yayon A., Vande Waa J. A., Yayon M., Geary T. G., Jensen J. B. Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool. 1983 Nov;30(4):642–647. doi: 10.1111/j.1550-7408.1983.tb05336.x. [DOI] [PubMed] [Google Scholar]
  48. Zhang Y., Asante K. S., Jung A. Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. J Parasitol. 1986 Dec;72(6):830–836. [PubMed] [Google Scholar]
  49. ter Kuile F. O., Dolan G., Nosten F., Edstein M. D., Luxemburger C., Phaipun L., Chongsuphajaisiddhi T., Webster H. K., White N. J. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet. 1993 Apr 24;341(8852):1044–1049. doi: 10.1016/0140-6736(93)92409-m. [DOI] [PubMed] [Google Scholar]
  50. ter Kuile F. O., Luxemburger C., Nosten F., Thwai K. L., Chongsuphajaisiddhi T., White N. J. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):660–664. doi: 10.1016/0035-9203(95)90435-2. [DOI] [PubMed] [Google Scholar]
  51. ter Kuile F. O., Nosten F., Thieren M., Luxemburger C., Edstein M. D., Chongsuphajaisiddhi T., Phaipun L., Webster H. K., White N. J. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis. 1992 Dec;166(6):1393–1400. doi: 10.1093/infdis/166.6.1393. [DOI] [PubMed] [Google Scholar]
  52. ter Kuile F. O., Nosten F., Thieren M., Luxemburger C., Edstein M. D., Chongsuphajaisiddhi T., Phaipun L., Webster H. K., White N. J. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis. 1992 Dec;166(6):1393–1400. doi: 10.1093/infdis/166.6.1393. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES